semaglutide o tirzepatide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide vs. Tirzepatide: What's the

Recent study found a troubling link between the use of semaglutide (marketed as Ozempic or Wegovy) and an increased risk of developing a potentially blinding eye condition known as NAION

Research suggests that GLP-1 users prefer sugar to artificial sweeteners, as they are increasingly attracted to more 'natural' food that feels 'worthwhile' with their smaller appetites

Eric Topol, a physician and writer who is widely recognized both as a leading researcher and a public voice on medicine and health

GLP-1/GIP Therapy Discontinuation: Why the How Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro) is weight regain after stopping therapy

For a 2mg dose of tirzepatide, the recommended administration volume is 0.1mL (100 microliters), delivered via subcutaneous injection

GLP-1